These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26658169)

  • 1. Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations.
    Guacci A; Chetta M; Rizzo F; Marchese G; De Filippo MR; Giurato G; Nassa G; Ravo M; Tarallo R; Rocco T; Operto FF; Weisz A; Coppola G
    Seizure; 2016 Jan; 34():26-8. PubMed ID: 26658169
    [No Abstract]   [Full Text] [Related]  

  • 2. Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children.
    Suvichapanich S; Jittikoon J; Wichukchinda N; Kamchaisatian W; Visudtibhan A; Benjapopitak S; Nakornchai S; Manuyakorn W; Mahasirimongkol S
    J Hum Genet; 2015 Aug; 60(8):413-7. PubMed ID: 25994870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations.
    Milh M; Villeneuve N; Chouchane M; Kaminska A; Laroche C; Barthez MA; Gitiaux C; Bartoli C; Borges-Correia A; Cacciagli P; Mignon-Ravix C; Cuberos H; Chabrol B; Villard L
    Epilepsia; 2011 Oct; 52(10):1828-34. PubMed ID: 21770924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
    Di Meglio C; Lesca G; Villeneuve N; Lacoste C; Abidi A; Cacciagli P; Altuzarra C; Roubertie A; Afenjar A; Renaldo-Robin F; Isidor B; Gautier A; Husson M; Cances C; Metreau J; Laroche C; Chouchane M; Ville D; Marignier S; Rougeot C; Lebrun M; de Saint Martin A; Perez A; Riquet A; Badens C; Missirian C; Philip N; Chabrol B; Villard L; Milh M
    Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation.
    Dilena R; Striano P; Traverso M; Viri M; Cristofori G; Tadini L; Barbieri S; Romeo A; Zara F
    Brain Dev; 2016 Jan; 38(1):128-31. PubMed ID: 26212315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folinic acid responsive epilepsy in Ohtahara syndrome caused by STXBP1 mutation.
    Tso WW; Kwong AK; Fung CW; Wong VC
    Pediatr Neurol; 2014 Feb; 50(2):177-80. PubMed ID: 24315539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S; Wafai ZA; Wani MA; Jan TR; Andrabi KI
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):504-16. PubMed ID: 25943175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V; Perucca E
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1269-79. PubMed ID: 26037375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
    Thakkar AN; Bendkhale SR; Taur SR; Gogtay NJ; Thatte UM
    Neurol India; 2012; 60(6):577-80. PubMed ID: 23287317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment with levetiracetam in a case of Ohtahara syndrome caused by STXBP1 mutation].
    Yamashita S; Chiyonobu T; Yoshida M; Moroto M; Morita T; Morioka S; Kato M; Saitsu H; Morimoto M; Hosoi H
    No To Hattatsu; 2013 Jan; 45(1):64-6. PubMed ID: 23593750
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N; Kabra M; Gulati S; Gupta YK; Pandey RM; Bhatia BD
    BMC Pediatr; 2016 May; 16():66. PubMed ID: 27179628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.
    Romaniello R; Zucca C; Tenderini E; Arrigoni F; Ragona F; Zorzi G; Bassi MT; Borgatti R
    J Child Neurol; 2014 Feb; 29(2):249-53. PubMed ID: 24170257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations.
    Deprez L; Weckhuysen S; Holmgren P; Suls A; Van Dyck T; Goossens D; Del-Favero J; Jansen A; Verhaert K; Lagae L; Jordanova A; Van Coster R; Yendle S; Berkovic SF; Scheffer I; Ceulemans B; De Jonghe P
    Neurology; 2010 Sep; 75(13):1159-65. PubMed ID: 20876469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-of-function mutations of STXBP1 in patients with epileptic encephalopathy.
    Yamamoto T; Shimojima K; Yano T; Ueda Y; Takayama R; Ikeda H; Imai K
    Brain Dev; 2016 Mar; 38(3):280-4. PubMed ID: 26384463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.
    Twardowschy CA; Werneck LC; Scola RH; De Paola L; Silvado CE
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):153-8. PubMed ID: 21537551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.
    Stamberger H; Nikanorova M; Willemsen MH; Accorsi P; Angriman M; Baier H; Benkel-Herrenbrueck I; Benoit V; Budetta M; Caliebe A; Cantalupo G; Capovilla G; Casara G; Courage C; Deprez M; Destrée A; Dilena R; Erasmus CE; Fannemel M; Fjær R; Giordano L; Helbig KL; Heyne HO; Klepper J; Kluger GJ; Lederer D; Lodi M; Maier O; Merkenschlager A; Michelberger N; Minetti C; Muhle H; Phalin J; Ramsey K; Romeo A; Schallner J; Schanze I; Shinawi M; Sleegers K; Sterbova K; Syrbe S; Traverso M; Tzschach A; Uldall P; Van Coster R; Verhelst H; Viri M; Winter S; Wolff M; Zenker M; Zoccante L; De Jonghe P; Helbig I; Striano P; Lemke JR; Møller RS; Weckhuysen S
    Neurology; 2016 Mar; 86(10):954-62. PubMed ID: 26865513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype?
    Barcia G; Chemaly N; Gobin S; Milh M; Van Bogaert P; Barnerias C; Kaminska A; Dulac O; Desguerre I; Cormier V; Boddaert N; Nabbout R
    Eur J Med Genet; 2014 Jan; 57(1):15-20. PubMed ID: 24189369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K; Liu Y; Ai CZ; Yu X; Li W
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):337-346. PubMed ID: 29628024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy is not a mandatory feature of STXBP1 associated ataxia-tremor-retardation syndrome.
    Gburek-Augustat J; Beck-Woedl S; Tzschach A; Bauer P; Schoening M; Riess A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):661-5. PubMed ID: 27184330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A; Hashimoto Y; Otsuki Y; Uwai Y; Hattori H; Furusho K; Inui K
    Clin Pharmacol Ther; 1997 Sep; 62(3):287-92. PubMed ID: 9333104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.